What is the ROE (Return on Equity) of Nicox this year?
The ROE of Nicox this year is -0.98 undefined.
Nicox ROE 2024
Nicox ROE
-0.98
Ticker
ALCOX.PA
ISIN
FR0013018124
WKN
A143G8
In 2024, Nicox's return on equity (ROE) was -0.98, a 84.19% increase from the -0.53 ROE in the previous year.
Nicox Aktienanalyse
What does Nicox do?
Nicox SA is a French pharmaceutical company specializing in the development and commercialization of innovative therapy systems for eye diseases. It was founded in 1996 as a spin-off of Nestlé's research activities in the field of ophthalmology. The company's business model is based on the development of drugs based on nitric oxide (NO), a gaseous molecule that plays an important role in regulating blood flow and inflammation processes in the human body. Nicox SA's technology allows for the targeted release of NO donors in specific areas of the eye to reduce disease-related inflammation and damage. This provides a promising alternative to conventional therapies for a range of eye diseases. Nicox SA is divided into three business areas: Ophthalmology, Diagnostics, and Contracts. In the Ophthalmology segment, the company focuses on the development of drugs for the treatment of glaucoma, dry eye, and other eye diseases. Important products in this area include Vyzulta, a combination of an NO donor and a glaucoma drug, as well as NCX 470, an NO donor for the treatment of glaucoma. In addition, the company is working on the development of NCX 4251, an NO donor for the treatment of blepharitis, an inflammation of the eyelids. In the Diagnostics segment, Nicox SA offers innovative diagnostic tests for ophthalmology based on tear fluid analysis. These tests enable ophthalmologists to diagnose and monitor certain eye diseases more quickly and accurately. Key products in this area include AdenoPlus, a rapid test for diagnosing adenovirus conjunctivitis, and ClearSight, a test for monitoring glaucoma patients. The Contracts segment offers customized clinical research services for customers in the pharmaceutical industry. This segment is an important part of Nicox SA's strategy to generate additional revenue and finance the development of new therapies. Overall, Nicox SA has a strong pipeline of new therapies and diagnostic tests that allow the company to consolidate its position as a leading provider of eye medications. The company works closely with its industry and academic research partners to develop and bring innovative therapies to the market. In summary, Nicox SA is an innovative and rapidly growing company focusing on the development and commercialization of therapies for eye diseases. The company has a strong pipeline of new products and services and collaborates closely with its partners to strengthen its position in the industry. Nicox ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Nicox's Return on Equity (ROE)
Nicox's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Nicox's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Nicox's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Nicox’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Nicox stock
How has the Return on Equity (ROE) of Nicox developed compared to the previous year?
The ROE of Nicox has increased by 84.19% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Nicox?
A high ROE indicates that Nicox generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Nicox?
A low ROE can indicate that Nicox is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Nicox affect the company?
A change in ROE (Return on Equity) of Nicox can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Nicox?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Nicox?
Some factors that can influence Nicox's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Nicox pay?
Over the past 12 months, Nicox paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nicox is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nicox?
The current dividend yield of Nicox is .
When does Nicox pay dividends?
Nicox pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nicox?
Nicox paid dividends every year for the past 0 years.
What is the dividend of Nicox?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nicox located?
Nicox is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nicox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nicox from 10/12/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/12/2024.
When did Nicox pay the last dividend?
The last dividend was paid out on 10/12/2024.
What was the dividend of Nicox in the year 2023?
In the year 2023, Nicox distributed 0 EUR as dividends.
In which currency does Nicox pay out the dividend?
The dividends of Nicox are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nicox stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nicox
Our stock analysis for Nicox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nicox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.